• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
JIANG Yaling, LI Ke, HUANG Wenlong, HU Guoqiang. Synthesis and antitumor activity of 3-(5-benzylidenethuzolo-triazlone)fluoroquinolones[J]. Journal of China Pharmaceutical University, 2018, 49(6): 671-675. DOI: 10.11665/j.issn.1000-5048.20180605
Citation: JIANG Yaling, LI Ke, HUANG Wenlong, HU Guoqiang. Synthesis and antitumor activity of 3-(5-benzylidenethuzolo-triazlone)fluoroquinolones[J]. Journal of China Pharmaceutical University, 2018, 49(6): 671-675. DOI: 10.11665/j.issn.1000-5048.20180605
shu

Synthesis and antitumor activity of 3-(5-benzylidenethuzolo-triazlone)fluoroquinolones

More Information
    Graphical Abstract
    • Abstract
  • To discover an efficient approach for the conversion of antibacterial fluoroquinolones into an antitumor activity, a fused heterocycle ring core, thiazolo［3, 2-b］［1, 2, 4］triazol-5-one was used as an isostere and further modified with an arylidene group. Then, 12 novel C-3 fused heterocyclic unsaturated ketones, 1- ethyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-3-［6-arylidene-thiazolo［3, 2-b］［1, 2, 4］triazol-5(6H)-one-3-yl］- quinolon-4(1H)-ones( 6a - 6l ), were designed and synthesized from pefloxacin( 1 ). The structures were characterized by elemental analysis and spectral data, and the in vitro antitumor activity of the title compounds against SMMC-7721, Capan-1 and HL60 cell lines was evaluated. The preliminary pharmacological results demonstrated that the title compounds exhibited more significantly antiproliferative activity than the parent 1 . The compounds with fluorophenyl or o-methoxyphenyl showed comparable activity to the comparasion doxorubicin. Thus, it appears to be an alternative route for a fused heterocyclic unsaturated ketone as an isostere of the C-3 carboxylic group to improve the antitumor activity.
    • FullText(HTML)
    • References (8)
  • [1]
    Guo ZR.R&D based on pharmacophore and scaffold hopping for imrecoxib[J].Acta Pharm Sin(药学学报),2018,53(8):1383-1386.
    [2]
    Hu W,Huang XS,Wu JF,et al.Discovery of novel topoisomerase II inhibitors by medicinal chemistry approaches[J].J Med Chem,2018,61(20):8947-8980.
    [3]
    Zhang HL,Li K,Zhao H,et al.Synthesis and antitumor activity of fluoroquinolone C-3 s-triazole Schiff- base carboxylic acid derivatives from pefloxacin(X)[J].J China Pharm Univ(中国药科大学学报),2017,48(2):167-171.
    [4]
    Yan Q,Ni LL,Wu SM,et al.Synthesis and antitumor activity of C-3 thiazolo [3,2-b][1,2,4] triazole substituted pefloxacin derivatives[J].J China Pharm Univ(中国药科大学学报).2015,46(5):548-551.
    [5]
    Yang T,Wang XM,Wang R,et al.Synthesis and antitumor activity of pefloxacin C-3(rhodanine unsaturated ketone)amide derivatives[J].J China Pharm Univ(中国药科大学学报),2017,48(5):543-547.
    [6]
    Song M.Progress in discovery of KIF5B-RET kinase inhibitors for the treatment of non-small-cell lung cancer[J].J Med Chem,2015,58(9):3672-3681.
    [7]
    Zhuang CL,Zhang W,Sheng CQ,et al.Chalcone:a privileged structure in medicinal chemistry[J].Chem Rev,2017,117(12):7762-7810.
    [8]
    Majumdar P,Pati A,Patra M,et al.Acid hydrazides,potent reagents for synthesis of oxygen-,nitrogen-,and/or sulfur-containing heterocyclic rings[J].Chem Rev,2014,114(5):2942-2977.
    • Related Articles

  • Related Articles

    [1]SHAO Shishuai, DUAN Shukang, TIAN Hong, YAO Wenbing, GAO Xiangdong. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine[J]. Journal of China Pharmaceutical University, 2023, 54(2): 245-254. DOI: 10.11665/j.issn.1000-5048.2023022803
    [2]CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
    [3]WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501
    [4]HE Junjin, WANG Jiayi, HAO Jingchao, CHENG Haoran, XU Hanmei. Antitumor effect of peptide mPEG-SC20k-HM-3 and oxaliplatin combination against human hepatocellular carcinoma SMMC-7721 in nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(4): 476-480. DOI: 10.11665/j.issn.1000-5048.20150415
    [5]CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]YANG Yong-fang, YAN Hai-qiang, DING Guo-fang, HUANG Fang-fang. Isolation and purification of an anticancer activity peptide from protein hydrolysate of Mytilus coruscus[J]. Journal of China Pharmaceutical University, 2011, 42(3): 272-275.
    [8]Research of anti-tumor peptide neutralizing antibodies activities[J]. Journal of China Pharmaceutical University, 2010, 41(2): 171-174.
    [9]Tumor microenvironment：A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10.
    [10]Studies on the Antitumor Principles of Herba Artemisiae capillaris[J]. Journal of China Pharmaceutical University, 1992, (5): 283-286.

Catalog

    Get Citation
    PDF
    XML
    Article views (548) PDF downloads (859) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366141

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return